Inflation and Interest Rate Outlook: Higher inflation and potential interest rate adjustments by the Federal Reserve (influenced by events like the US March PCE Index and FOMC meetings) could impact Abbott's borrowing costs, consumer spending on healthcare products, and overall valuation through changes in discount rates.

Global Supply Chain Disruptions and Geopolitical Tensions: Abbott's global operations and extensive supply chain are vulnerable to geopolitical tensions, such as those in the Middle East. These tensions can lead to increased costs for freight and raw materials, disruptions in supply, and broader economic instability in markets where the company operates, affecting its profit margins.

Healthcare Spending and Regulatory Environment: Changes in global healthcare expenditures, shifts in reimbursement policies for medical devices and diagnostics (including continuous glucose monitoring and new cancer detection tools), and evolving regulatory landscapes in different countries can significantly influence Abbott's revenue streams and profitability. Examples include market-specific weaknesses like those in China and adjustments in funding for HIV testing.